bisoprolol fumarate hydrochlorothiazide- Bisoprolol Fumarate and hydrochlorothiazide tablet, film coated United States - English - NLM (National Library of Medicine)

bisoprolol fumarate hydrochlorothiazide- bisoprolol fumarate and hydrochlorothiazide tablet, film coated

watson laboratories, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - tablet, film coated - 2.5 mg - bisoprolol and hydrochlorothiazide is indicated in the management of hypertension. bisoprolol and hydrochlorothiazide is contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

BISOPROLOL FUMARATE tablet United States - English - NLM (National Library of Medicine)

bisoprolol fumarate tablet

carilion materials management - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - bisoprolol fumarate 5 mg - bisoprolol fumarate is indicated in the management of hypertension. it may be used alone or in combination with other antihypertensive agents. bisoprolol fumarate is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree av block, and marked sinus bradycardia.

BISOPROLOL TABLET Canada - English - Health Canada

bisoprolol tablet

sivem pharmaceuticals ulc - bisoprolol fumarate - tablet - 5mg - bisoprolol fumarate 5mg - beta-adrenergic blocking agents

BISOPROLOL TABLET Canada - English - Health Canada

bisoprolol tablet

sivem pharmaceuticals ulc - bisoprolol fumarate - tablet - 10mg - bisoprolol fumarate 10mg - beta-adrenergic blocking agents

BISOPROLOL AN  bisoprolol fumarate 1.25mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

bisoprolol an bisoprolol fumarate 1.25mg tablet blister pack

amneal pharma australia pty ltd - bisoprolol fumarate, quantity: 1.25 mg - tablet, film coated - excipient ingredients: crospovidone; colloidal anhydrous silica; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of stable chronic moderate to severe heart failure in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.